News
Pharma CEOs may be subpoenaed as IRA dispute rumbles on
US Senator Bernie Sanders has said he plans to hold a vote on 31st …
19751 items found
Digital
Redefining chronic disease management with novel digital solutions
Chronic medical conditions such as heart disease, diabetes, and …
Sales & Marketing
Sponsored
Take pharma brand planning to the next level in 2024
Today, pharma brand planning teams can benefit from technology …
News
AZ bags first approval for PNH therapy danicopan, in Japan
AstraZeneca has claimed its first regulatory approval for oral Factor …
R&D
News
CG Oncology lines up $180m IPO and a $1bn valuation
CG Oncology is the latest biotech to take a look at a share listing …
News
FDA turns down Satsuma’s nasal migraine treatment
Manufacturing problems have scuppered Satsuma Pharmaceuticals’ …
News
NICE backs Pfizer’s Talzenna for advanced breast cancer
Pfizer’s PARP inhibitor Talzenna has become the first targeted …
News
BridgeBio raises $1.25bn, and other biotech financings
Our round-up of recent biotech financings is headed by a massive …
R&D
Partner Content
5th Gene Therapy Analytical Development Europe Summit returns to Boston!
As the approvals for gene therapy in Europe are expected to increase …
R&D
Partner Content
7th Gene Therapy for Rare Disorders Summit returns to Boston!
2023 saw more gene therapies approved by the FDA than the previous …
R&D
Partner Content
Viral Vector Process Development & Manufacturing Summit Returns to Boston!
With the FDA’s fast-evolving quality assessment and lack of standard …
News
Novartis gets FDA okay for frontline use of Scemblix in CML
Novartis has picked up a new FDA approval for its chronic myeloid leukaemia therapy Scemblix that it believes is critical to unlocking the drug's blockbuster sales potential.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
